Research Article
Open access
Published on 26 September 2024
Download pdf
Fan,Y. (2024).Association between biological markers and somatic pain.Theoretical and Natural Science,54,1-6.
Export citation

Association between biological markers and somatic pain

Yinhui Fan *,1,
  • 1 Capital University of Physical Education and Sports

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/54/2024AU0108

Abstract

Pain, as one of the major clinical and social problems, still lacks effective objective evaluation indicators. At present, nearly one in five adults suffer from different types and different parts of pain. An important feature of clinical pain is persistent pain, in addition to sensory discrimination processes, it involves a range of brain regions involved in top-down cognitive and emotional processing. However, clinical pain is often affected by multiple factors and is difficult to assess objectively. Recently, blood, urine, cerebrospinal fluid, and biopsy tissue have been identified using novel, sensitive, and specific protein analysis methods in an attempt to detect changes in biological markers associated with different pain types. This paper will summarize the biological markers related to different parts of pain in the latest relevant studies at home and abroad and focus on the application prospect of such biological markers in the diagnosis, treatment, and prognosis evaluation of the pain.

Keywords

Pain, biological markers, application

[1]. Xue YA-Qian, ZHAO Ming-Liang, Gong Ping, et al. Application of exosomes in the standardized management of chronic pain [J]. Armed Police Medicine, 2019,34(10):913-917. (in Chinese).

[2]. Lumley, S., Yu, D., Wilkie, R., Jordan, K. P., & Peat, G. (2024). Chronic pain-mental health comorbidity and excess prevalence of health risk behaviours: a cross-sectional study. Primary health care research & development, 25, e15. https://doi.org/10.1017/S1463423624000070

[3]. Gevers-Montoro, C., Puente-Tobares, M., Monréal, A., Conesa-Buendía, F. M., Piché, M., & Ortega-De Mues, A. (2023). Urinary TNF-α as a potential biomarker for chronic primary low back pain. Frontiers in integrative neuroscience, 17, 1207666. https://doi.org/10.3389/fnint.2023.1207666

[4]. Xu Wei, Sheng Jun, Liu Da, et al. Correlation between bone mineral density and bone turnover markers and lumbar Modic changes in postmenopausal women with low back pain [J]. Chinese Journal of Osteoporosis, 2019,27(10):1454-1457,1468.

[5]. Salas-Fraire, O., Rivera-Pérez, J. A., Guevara-Neri, N. P., Urrutia-García, K., Martínez-Gutiérrez, O. A., Salas-Longoria, K., & Morales-Avalos, R. (2023). Efficacy of whole-body cryotherapy in the treatment of chronic low back pain: Quasi-experimental study. Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 28(1), 112–116. https://doi.org/10.1016/j.jos.2021.10.006

[6]. Kim, Sang-guk, Lee, Sang-wook, & Kim, Jae-hee. (2010). The effects of a rehabilitation exercise program on pain and inflammatory markers in workers with low back pain due to injury. Korean Journal of Health Promotion, 10(3), 131-138.

[7]. González-Callejas, C., Aparicio, V. A., De Teresa, C., & Nestares, T. (2020). Association of Body Mass Index and Serum Markers of Tissue Damage with Postoperative Pain. The Role of Lactate Dehydrogenase for Postoperative Pain Prediction. Pain medicine (Malden, Mass.), 21(8), 1636–1643. https://doi.org/10.1093/pm/pnz325

[8]. Chinese Medical Association Obstetrics and Gynecology Physicians Branch Endometriosis Collaborative Group, Chinese Medical Association Obstetrics and Gynecology Physicians Branch. Guidelines for the Diagnosis and Treatment of Endometriosis (Third Edition). Chinese Journal of Obstetrics and Gynecology, 2021, 56(12), 812-824.

[9]. Kristiansson, P., Svärdsudd, K., & von Schoultz, B. (1999). Reproductive hormones and aminoterminal propeptide of type III procollagen in serum as early markers of pelvic pain during late pregnancy. American journal of obstetrics and gynecology, 180(1 Pt 1), 128–134. https://doi.org/10.1016/s0002-9378(99)70162-6

[10]. Zhang, Siya, Liu, Xiaolong, Hu, Yanqi, et al. Manual Therapy for Neck Pain Patients: Interpretation of Best Practice Guidelines. Chinese Journal of General Practice, 2023, 26(11), 1305-1309.

[11]. Sekijima, Y., Yoshida, T., & Ikeda, S. (2010). CPPD crystal deposition disease of the cervical spine: a common cause of acute neck pain encountered in the neurology department. Journal of the neurological sciences, 296(1-2), 79–82. https://doi.org/10.1016/j.jns.2010.05.028

[12]. Takasu, S., Takatsu, S., Kunitomo, K., & Kokumai, Y. (1994). Serum hyaluronic acid and interleukin-6 as possible markers of carpal tunnel syndrome in chronic hemodialysis patients. Artificial organs, 18(6), 420–424. https://doi.org/10.1111/j.1525-1594.1994.tb02227.x

[13]. Fujibayashi, K., Kawai, Y., Kitayama, M., Akao, H., Ishida, R., Motoyama, A., Wakasa, M., Arakawa, K., Ueki, M., Kajinami, K., & Yasuda, T. (2012). Serum deoxyribonuclease I activity can be a useful diagnostic marker for the early diagnosis of unstable angina pectoris or non-ST-segment elevation myocardial infarction. Journal of cardiology, 59(3), 258–265. https://doi.org/10.1016/j.jjcc.2012.01.005

[14]. Mainale, D. (2005). Evaluation of serum cardiac troponin-I (CTnI) as a more sensitive marker than serum ckmb in the early diagnosis of acute myocardial infarction (ami). (Order No. 30577309, Rajiv Gandhi University of Health Sciences (India)). PQDT - Global, , 121. Retrieved from https://www.proquest.com/dissertations-theses/evaluation-serum-cardiac-troponin-i-ctni-as-more/docview/2848773105/se-2

[15]. Duman, Ali & Ozkan, Seda & Durukan, Polat & Avsaroglu, Levent & Muhtaroglu, Sabahattin & Ipekci, Afsin & Koyuncu, Murat. (2016). Diagnosis of fatal chest pain with copeptin levels. Biomedical Research. 27. 812-815.

Cite this article

Fan,Y. (2024).Association between biological markers and somatic pain.Theoretical and Natural Science,54,1-6.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content

About volume

Volume title: Proceedings of Workshop on Intelligent Medical Data Analysis for Precision Medicine - ICBioMed 2024

Conference website: https://2024.icbiomed.org/
ISBN:978-1-83558-629-7(Print) / 978-1-83558-630-3(Online)
Conference date: 25 October 2024
Editor:Byeongsang Oh
Series: Theoretical and Natural Science
Volume number: Vol.54
ISSN:2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).